Search - tctmd.com

Displaying 221 - 240 of 257

Sort: Relevancy | Date

News Conference News CRT 2020

Operator Volume Matters in Left Main PCI: BCIS Analysis

Michael O'Riordan

March 05, 2020

News Features

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Michael O'Riordan

March 03, 2020

News Conference News CRT 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Michael O'Riordan

February 28, 2020

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Shelley Wood

February 28, 2020

News Conference News CRT 2020

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

Michael O'Riordan

February 25, 2020

News Conference News CRT 2020

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

L.A. McKeown

February 25, 2020

News Daily News

Sudden Cardiac Death Is Often First CVD Presentation in Women

L.A. McKeown

February 24, 2020

News Conference News CRT 2020

Good Coronary Collateral Circulation? Better LVEF and Survival After STEMI

Michael O'Riordan

February 24, 2020

News Conference News CRT 2020

Meta-analysis Upholds Complete PCI in STEMI, as Thoughts Turn to Timing, Costs

Michael O'Riordan

February 24, 2020

News Daily News

BBC Makes New EXCEL Allegations, Says Investigators Ignored Safety Concerns

Michael O'Riordan

February 21, 2020

News Daily News

Acute MI Symptom Clustering Differs in Men and Women: VIRGO

Michael O'Riordan

February 21, 2020

News Daily News

PCI for Preventing Death in Unstable vs Stable CAD: New Data, More Soul-searching

Shelley Wood

February 19, 2020

News Daily News

Early CVD Readmissions and Mortality Patterns Differ in Canada and the US

Yael L. Maxwell

February 18, 2020

News Daily News

Snapshot of Revascularization Outcomes Offers Some Reassurances, Some Surprises

Shelley Wood

February 14, 2020

Presentation JIM 2020

Optimal LDL levels in patients with ACS undergoing PCI

Presenter: Giuseppe Musumeci

February 13, 2020

Presentation JIM 2020

Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs

Presenter: Dominick Angiolillo

February 13, 2020

Presentation JIM 2020

Intravenous antiplatelet therapy in high risk ACS:GPIIb/IIIa inhibitors are still a good option

Presenter: Marco Ferlini

February 13, 2020

News Daily News

Outcome Differences Between Men and Women With PAD: EUCLID Insights

L.A. McKeown

February 11, 2020

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

News Daily News

ACS After TAVR a Unique Condition With Poor Prognosis

Todd Neale

February 05, 2020

Advertisement

Operator Volume Matters in Left Main PCI: BCIS Analysis

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

Sudden Cardiac Death Is Often First CVD Presentation in Women

Good Coronary Collateral Circulation? Better LVEF and Survival After STEMI

Meta-analysis Upholds Complete PCI in STEMI, as Thoughts Turn to Timing, Costs

BBC Makes New EXCEL Allegations, Says Investigators Ignored Safety Concerns

Acute MI Symptom Clustering Differs in Men and Women: VIRGO

PCI for Preventing Death in Unstable vs Stable CAD: New Data, More Soul-searching

Early CVD Readmissions and Mortality Patterns Differ in Canada and the US

Snapshot of Revascularization Outcomes Offers Some Reassurances, Some Surprises

Optimal LDL levels in patients with ACS undergoing PCI

Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs

Intravenous antiplatelet therapy in high risk ACS:GPIIb/IIIa inhibitors are still a good option

Outcome Differences Between Men and Women With PAD: EUCLID Insights

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

ACS After TAVR a Unique Condition With Poor Prognosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content